ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
{{output}}
Aberrant activation of RET is a critical driver of growth and proliferation in diverse solid tumours. Multikinase inhibitors (MKIs) showing anti-RET activities have been tested in RET-altered tumours with variable results. The low target specificity with conse... ...
